FDA Moves Forward on Aducanumab
By
Phil Gutis
| August 7th, 2020
In yet another encouraging step toward the development of what could be the first drug approved for Alzheimer’s disease, the Federal Drug Administration today…
Researchers Explore Lithium as Treatment for Alzheimer’s Disease
By Lecia Bushak | January 29th, 2020
Whether it’s diet, exercise or air pollution, researchers are constantly investigating lifestyle and environmental factors that may play a role in the progression or…
FDA Gives Biogen Green Light to Relaunch Aducanumab Study on Trial Participants
By Phil Gutis | January 28th, 2020
The U.S. Food and Drug Administration (FDA) has approved a re-dosing study for patients formerly enrolled in Biogen’s phase three clinical trials of its…
China’s ‘Seaweed’ Alzheimer’s Drug Is Now Available to Patients
By Lecia Bushak | December 30th, 2019
An experimental “seaweed” drug called Oligomannate, which treats Alzheimer’s, is now available for patients to buy in China. Chinese officials announced conditional approval to…
An HIV Drug to Treat Alzheimer’s? Researchers See Promising Results in Mice
By Lecia Bushak | December 20th, 2019
As research into a cure – or at least treatment – for Alzheimer’s continues, scientists are looking beyond the pathways of targeting tau or…
Will Biogen’s Drug Aducanumab Solve the Alzheimer’s Mystery?
By
Tanner Jensen
| December 13th, 2019
Last week, Biogen announced that its Alzheimer’s drug aducanumab was effective in combating Alzheimer’s disease, and that it would be reviving a trial cancelled…
Clinical Trial Participant Reacts to News Biogen’s Alzheimer’s Drug May Have Been Working
By
Being Patient
| December 13th, 2019
Clinical Trial Participant Reacts to News Biogen's Alzheimer's Drug Aducanumab May Have Been WorkingWatch this video on YouTube Biogen has announced new data behind…
Follow us